DCF — AULTMAN HOSPITAL
Enterprise Value: $-569.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-569.0M
Enterprise Value
$-188.3M
PV of Cash Flows
$-380.6M
PV of Terminal Value
$-613.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $603.8M | $-30.9M | -5.0% | $-56.5M | $-51.3M |
| Year 2 | $621.9M | $-25.6M | -4.0% | $-51.9M | $-42.9M |
| Year 3 | $640.5M | $-20.0M | -3.0% | $-47.1M | $-35.4M |
| Year 4 | $659.8M | $-17.3M | -3.0% | $-45.2M | $-30.9M |
| Year 5 | $679.6M | $-16.1M | -2.0% | $-44.9M | $-27.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-569.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$586.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.056176466406169974
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5